Clinical features of 32 patients after 8 years of a liver transplant

Transplantation Proceedings

Volumn 31, Issue 6, 1999, Pages 2475-2476

  Loinaz, C ^a   Marques E ^a   Gomez R ^a   Jimenez C ^a   Gonzalez Pinto I ^a   Citores, M A ^a   Musella, M ^a   Garcia, I ^a   Moreno, E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; REOPERATION; TIME FACTORS;

EID: 0032830729     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(99)00424-8     Document Type: Conference Paper

References (3)

1. Moreno González E., Loinaz C., García I., et al. J Hepatol. 17:(suppl 3):1993;S116.
2. Karnofsky D.A., Abelmann W.H., Craver L.F., et al. Cancer. 1948;634.
3. Valero M.A., Loinaz C., Larrodera L., et al. Calcif Tissue Int. 57:1995;15.